Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma

R Suzuki, Y Kitamura, D Ogiya, Y Ogawa… - International Journal of …, 2022 - Springer
Abstract RAS/RAF/MEK/ERK pathway inhibitors exhibit significant anti-tumor effects against
various tumor types, including multiple myeloma (MM), and they are predicted to play a …
被引用次数：3 相关文章

Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma

R Suzuki, Y Kitamura, D Ogiya… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
RAS/RAF/MEK/ERK pathway inhibitors exhibit significant anti-tumor effects against various
tumor types, including multiple myeloma (MM), and they are predicted to play a pivotal role …

Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma

S Rikio, K Yuka, O Daisuke, O Yoshiaki… - International …, 2022 - search.proquest.com
Abstract RAS/RAF/MEK/ERK pathway inhibitors exhibit significant anti-tumor effects against
various tumor types, including multiple myeloma (MM), and they are predicted to play a …

Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma.

R Suzuki, Y Kitamura, D Ogiya, Y Ogawa… - International Journal …, 2021 - europepmc.org
RAS/RAF/MEK/ERK pathway inhibitors exhibit significant anti-tumor effects against various
tumor types, including multiple myeloma (MM), and they are predicted to play a pivotal role …

[引用][C] Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma

R Suzuki, Y Kitamura, D Ogiya, Y Ogawa… - International Journal of …, 2021 - cir.nii.ac.jp
Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in
multiple myeloma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …